The Myelin Medical Manifesto

Dr Jack Parry 5 May 2026

keywords: manifesto myelin mind therapeutic direction PTSD schizophrenia Alzheimer’s stroke depression chronic pain addiction white matter oligodendrocyte accumulated condition

The Myelin Mind began as an explanation. It asked why: why consciousness arises at the encounter between incoming signal and accumulated myelinated condition, why the self is inscribed in white matter rather than in the firing of neurons, why every condition most associated with the loss of self is consistently associated with white matter pathology. Forty articles and a doctoral thesis later, the explanation is sufficiently built. The question has changed.

The question is now: what do we do about it?

This is not a rhetorical shift. It is a scientific one. An explanatory framework that cannot generate therapeutic directions is a description of the problem rather than a contribution to its solution. The Myelin Mind has something to say about what can be done, and this article says it.

The accumulated myelinated condition is the biological substrate of the self. It is built through genuine encounter with the world, through productive struggle, through sleep, through movement, through sustained attention, through connection with others. It is degraded by chronic stress, by inflammatory environments, by pharmacological interference, by the sustained mechanical load of a phone held at sixty degrees of neck flexion, by poverty, by the absence of the conditions under which genuine encounter is possible.

A better myelinated world is one that understands this and acts accordingly. It is not a utopia. It is a research agenda and a policy direction and a clinical reorientation, grounded in thirty years of biology that the dominant framework has not yet integrated.

Here is where to begin.

PTSD is a white matter problem.

The existing frameworks treat PTSD as a memory disorder, an anxiety disorder, a failure of emotional regulation. These are accurate descriptions of its phenomenology. They are not adequate accounts of its biology. Post-traumatic stress disorder is hypermyelination of the trauma signal: the catastrophic inscription of a threat encounter so intense that the accumulated myelinated condition reorganises itself around the false signal, making the threat permanent, inescapable, present in every subsequent chiasm event.

The therapeutic question this generates is new and the existing literature has not yet asked it. Not: how do we process the trauma? But: how do we degrade a specific hypermyelinated pathway without wholesale demyelination of the self that surrounds it? The kappa opioid receptor literature suggests one pharmacological route. The extinction and reconsolidation literature suggests an experiential one. The ketamine finding, that its long-lasting antidepressant effect depends on OPC differentiation, suggests that the pharmacological and the biological may be the same route approached from different directions. The research agenda is to map these routes and establish which produces measurable white matter microstructural change in the PTSD-specific pathways as measured by DTI.

This is a fundable and testable research direction. It is also a genuinely new one.

Schizophrenia can be prevented, at least in some cases, and the window is known.

The developmental window of adolescent frontal myelination is the most vulnerable period in the formation of the accumulated myelinated condition. The Mille Plateaux article on this site establishes that schizophrenia is interrupted plateau formation: the frontal white matter does not complete its stratification in the critical developmental window, and the chiasm between incoming signal and accumulated condition never forms adequately.

The research direction is preventive rather than curative. Identify at-risk adolescents during the critical window, not after the first psychotic episode but before it, using the white matter biomarkers that are already measurable by DTI. Support OPC differentiation through the interventions the biology identifies: exercise, sleep, reduction of cannabis exposure, removal of agents that arrest OPC maturation, including montelukast in a population for whom it was never monitored. This is not treatment. It is the creation of conditions in which the plateau can complete.

Clozapine is the drug of last resort in treatment-resistant schizophrenia, and it supports the myelination process in oligodendrocytes in ways that haloperidol does not. A research direction that asks what non-pharmacological interventions produce the same OPC differentiation effect during the developmental window, before the plateau formation has failed, is both clinically actionable and scientifically tractable.

Alzheimer’s disease can be slowed by maintaining the accumulated condition.

The amyloid hypothesis has driven drug development for three decades with limited clinical success. The Myelin Mind does not replace it. It adds what it has been missing: an account of why the accumulated self degrades in Alzheimer’s disease that points toward maintenance rather than cure.

If the accumulated myelinated condition is the biological substrate of the self, then the progressive dissolution of the self in Alzheimer’s is the progressive degradation of the white matter infrastructure that sustains it. The donepezil finding suggests that the most prescribed Alzheimer’s drug is already, inadvertently, supporting the myelination process through nicotinic receptor activation. The bilingualism literature establishes that sustained meaningful engagement with a second language maintains white matter integrity in language pathways across the lifespan. The music practice literature establishes that sustained musical répétition maintains white matter in auditory-motor and interhemispheric pathways.

The research direction is: what specific, sustained, meaningful engagements maintain white matter microstructural integrity in the pathways most vulnerable to Alzheimer’s-related degradation, and what is the minimum effective dose of that engagement? This is not a lifestyle recommendation. It is a pharmacological question asked of a non-pharmacological intervention, using DTI as the outcome measure.

The answer, the Myelin Mind predicts, will be that sustained genuine encounter, with language, with music, with craft, with other people, with problems that demand real responses, is the most effective white matter maintenance intervention available, and it is free.

Stroke rehabilitation needs to restore the intentional arc, not just the movement.

The seed grant Make a Difference with Repetition is already pursuing this direction. The argument is simple and the biology supports it: meaningful, intention-driven repetition produces stronger white matter remodelling than non-specific exercise, because activity-dependent myelination responds to the signal of genuine motor intention rather than to movement per se. The animated observation of graceful, purposive movement activates the mirror neuron system and the motor white matter simultaneously, beginning the remyelination of the damaged pathway before the movement can be physically executed.

This framework extends beyond stroke to every condition in which the intentional arc has been interrupted: Parkinson’s disease, cerebral palsy, spinal cord injury at the level where Schwann cell myelination meets oligodendrocyte myelination at the dorsal root ganglion. The research direction is to ask, for each of these conditions, what form of meaningful, animated, graceful movement observation produces the strongest white matter response in the damaged pathways, and what is the optimal sequence of observation, attempted execution, and rest that drives the OPC differentiation that makes remyelination possible.

Chronic pain is a myelinated inscription, not a signal.

The central sensitisation literature is already pointing at the myelinated pathway as the site of chronic pain maintenance. The tooth hurty article on this site asks the relevant clinical question: is the pain in the peripheral source, or has the accumulated myelinated condition of the pain pathway already taken over? The answer determines the treatment.

DRG stimulation targets the peripheral-central chiasm directly, modulating the accumulated condition at the junction between Schwann cell myelination and oligodendrocyte myelination. It is the most targeted intervention available because it addresses the chiasm rather than either the peripheral source or the central accumulation in isolation. The research direction is to extend the DRG stimulation framework across the range of chronic pain conditions, using DTI to measure white matter microstructural change in the pain pathways before and after intervention, and to identify the pharmacological and experiential co-interventions that support the white matter remodelling that lasting pain relief requires.

Depression is a thin chiasm, and exercise is the pharmacology.

The serotonin hypothesis has collapsed under systematic review. The Myelin Mind replacement: depression is a thinning of the accumulated myelinated condition, a self whose white matter is insufficiently stocked to generate resonance from the signals the world sends. The exercise finding confirms this directly. Exercise promotes OPC differentiation and myelination in the hippocampus more effectively than SSRIs. It is not a lifestyle adjunct to pharmacological treatment. It is the pharmacological treatment, acting on the myelination process that the SSRI does not reach.

The research direction is to establish exercise as a first-line myelination intervention in depression, to identify the minimum effective dose, to determine whether the OPC differentiation it promotes is measurable by DTI, and to design programs that combine the productive struggle of genuine physical effort with the meaning that makes the effort worth sustaining. The well-stocked chiasm article on this site describes the direction. The research agenda is to make it clinical.

Addiction rewrites the self in the wrong direction, and ibogaine may begin to rewrite it back.

The addiction literature has established measurable white matter reorganisation across substance use disorders. The Myelin Mind account: addiction is catastrophic myelination toward a false signal, the accumulated condition progressively rewritten around the pharmacological encounter that the myelination process cannot distinguish from the real one.

Ibogaine upregulates myelin basic protein and CNPase in the internal capsule of opioid-exposed animals. It is doing something in white matter that no other anti-addiction agent does, and the research direction is to understand that something: to map the white matter changes ibogaine produces using DTI, to establish whether they correlate with clinical outcomes, and to determine whether the kappa opioid receptor mechanism that drives its white matter effect can be separated from the other pharmacological actions that make ibogaine clinically difficult to administer.

Statins in aged care need to be reevaluated as myelination antagonists.

Myelin is one of the most cholesterol-rich biological structures in the body. Oligodendrocytes synthesise cholesterol locally, independently of peripheral cholesterol metabolism, to build and maintain the myelin sheath. Statins, which inhibit the mevalonate pathway and reduce cholesterol synthesis systemically, cross the blood-brain barrier and reduce the cholesterol available to oligodendrocytes for this process. The clinical trials that established statin safety and efficacy for cardiovascular outcomes did not use DTI as an outcome measure. Nobody was looking at white matter.

In aged populations, where the accumulated myelinated condition is already under progressive metabolic pressure, and where the OPCs that could maintain and repair it are operating in an increasingly inflammatory environment, statins may be accelerating the white matter degradation they were never assessed for. The cognitive side effects reported by a significant proportion of statin users, the brain fog, the memory difficulties, the sense of cognitive dimming, are consistent with a drug that is reducing the substrate available for myelin maintenance in the brain. These reports have been largely dismissed as subjective and inconsistent. The Myelin Mind framework makes them biologically plausible and suggests a research direction: DTI measurement of white matter microstructural change in aged populations before and after statin initiation, and assessment of whether statin type, dose, and lipophilicity correlate with the degree of white matter effect.

This is not a case against statins in all populations. It is a case for reassessing their use in aged care specifically, where the cardiovascular benefit may be marginal at advanced age and the myelination cost may be substantial.

Isolation in aged care is a biological intervention, and it is the wrong one.

The accumulated myelinated condition does not become static in old age. OPCs remain present in the adult brain throughout the lifespan and continue to respond to the signal of genuine engagement. Activity-dependent myelination does not stop. It slows, and the inflammatory environment of ageing makes it harder, but it continues as long as the signal that drives it is present. The signal is genuine encounter: real conversation, purposive activity, the specific productive struggle of being with another person who requires and provides a real response.

The aged care resident who sits alone in front of a television is not simply lonely. They are in a state of enforced myelination deprivation. The passive screen does not drive OPC differentiation. It provides signal without encounter, reception without response, the chiasm receiving without having to meet anything. The accumulated myelinated condition that is the biological self, built through decades of genuine encounter, is being maintained in an environment that provides almost none of the signals that built it.

The remedy is not complex and it is not expensive. Genuine conversation. Music, listened to or made. Gardens. Animals. Children who ask real questions and require real answers. Games that demand genuine attention. The productive struggle of learning something new at eighty, which the white matter will respond to with the same OPC differentiation that it responded to at eight, because the biology of the encounter does not know how old the person having it is. It knows only whether the encounter is genuine.

Isolation in aged care is a policy failure dressed as a resource constraint. The biological cost is borne by the white matter of the most myelination-vulnerable population in the healthcare system. A better myelinated world provides the conditions of genuine encounter to every person in every stage of life, including and especially the last ones.

A better myelinated world is also a more just one.

Poverty is demyelinating. Chronic stress suppresses OPC differentiation through sustained cortisol elevation. Restricted sleep prevents the glymphatic clearance and white matter consolidation that the myelination process requires. The absence of the conditions under which genuine encounter is possible, the productive struggle, the meaningful connection, the sustained engagement with difficulty that the accumulated myelinated condition requires to build itself, is a deprivation as biological as iodine deficiency or vitamin D insufficiency.

The neurologists who decline to see patients without private insurance are not making a clinical decision. They are making an economic one, and the biological consequence is borne entirely by the patient’s white matter. The pharmaceutical companies that did not monitor the impulse control consequences of dopamine agonists in women with restless legs syndrome were not committing a regulatory oversight. They were conducting a systematic experiment on a predominantly female population without consent, the results of which are now visible in the lives of people like Sally Gardner.

The tech manufacturers who distributed a device that produces sixty degrees of neck flexion loading to children without a single phase of safety testing are not being innovative. They are being reckless with the accumulated myelinated condition of a generation that has no comparison cohort, and whose cervical spines will not reveal the full extent of the experiment for another thirty years.

A better myelinated world holds these actors to account with the same rigour it applies to pharmaceutical manufacturers, because the biological consequences of their decisions land in white matter with the same specificity as any drug.

The Myelin Mind began as an explanation of consciousness, grounded in a doctoral thesis, confirmed by forty articles and a body of white matter literature that was already pointing at the right answer without knowing the framework that would make it legible.

The explanation is built. The framework is named. The biological substrate of the self has been identified, its vulnerabilities mapped, its conditions of health and degradation described across more than a dozen clinical domains.

What remains is the work. The research proposals, the clinical trials, the policy arguments, the educational interventions, the therapeutic protocols that follow from the biology. The shift from why to how.

A self is what the chiasm makes of a life of genuine encounter. A better myelinated world is one that understands this and creates the conditions, biological, clinical, social, educational, and regulatory, under which that encounter is possible for everyone.

That is the direction.

Jack Parry is a philosopher, polyglot, biomedical animator and cross-disciplinary eidetic researcher at Swinburne University of Technology. His research methodology employs moderated stochastic harnessing as a means of generating new knowledge across disciplinary boundaries. He is the author of The Myelin Mind: The Genesis of Meaning.